BFC Planning’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
BFC Planning's PBE Position: Q3 2026 in Review
BFC Planning opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q3 2026: 29,325 shares worth $2.85M. The stake represents 0.11% of the portfolio and ranks #183 among its holdings.
106 funds tracked by Wall St. Rank hold PBE as of Q3 2026.
- BFC Planning held 29,325 shares of Invesco Biotechnology & Genome ETF worth $2.85M as of Q3 2026.
- Invesco Biotechnology & Genome ETF was a new BFC Planning position in Q3 2026.
- Invesco Biotechnology & Genome ETF made up 0.11% of BFC Planning's portfolio in Q3 2026, its #183 holding.
- 106 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.